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Abstract The endothelium plays an important role in the
exchange of molecules, but also of immune cells between
blood and the underlying tissue. The endothelial molecule
S-Endo 1 antigen (CD146) is preferentially located at endo-
thelial junctions and has been claimed to support endothe-
lial integrity. In this study we show that the monoclonal
antibody ME-9F1 recognizes the extracellular portion of
murine CD146. Making use of ME-9F1 we found CD146
highly expressed and widely spread on endothelial cells in
the analyzed murine tissues. In contrast to humans that
express CD146 also on T cells or follicular dendritic cells,
murine CD146 albeit at low levels was only found on a sub-
set of NK1.1+ cells. The antibody against murine CD146 is
useful for immunomagnetic sorting of primary endothelial
cells not only from the liver but from various other organs.
In vitro, no evidence was seen that the formation and integ-
rity of endothelial monolayers or the transendothelial
migration of T cells was aVected by antibody binding to
CD146 or by crosslinking of the antigen. This makes the
antibody ME-9F1 an excellent tool especially for the ex
vivo isolation of murine endothelial cells intended to be
used in functional studies.
Keywords Antibody ME-9F1 · Endothelial cells · 
NK cells · Tissue distribution of murine CD146
Abbreviations
AcLDL Acetylated low density lipoprotein
CXCL12 CXC-chemokine ligand 12
FITC Fluorescein isothiocyanate
LSEC Liver sinusoidal endothelial cells
LYVE-1 Lymphatic vessel endothelial hyaluronic
acid receptor
mab Monoclonal antibody
MALDI-MS Matrix-assisted laser-desorption 
ionization mass spectrometry
NK Natural killer cell
TCR T cell receptor
VE-cadherin Vascular endothelial cadherin
Introduction
The vascular endothelium forms a continuous monolayer
on the inner surface of the vessel wall and acts as a barrier
between circulating blood and underlying tissues. Concom-
itantly, it functions as a Wlter and establishes communica-
tion between both compartments (Bazzoni 2006).
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Several adhesion molecules are currently used as endo-
thelial cell markers. The endothelium speciWc vascular
endothelial cadherin (VE-cadherin, CD144) is restricted to
interendothelial adherence junctions and plays a role for
paracellular permeability and maintenance of cell polarity
(Gao et al. 2000; Gotsch et al. 1997; Lampugnani et al.
1995). CD31, platelet endothelial cell adhesion molecule 1
(Piali et al. 1993; Vecchi et al. 1994) is additionally found
on leukocytes. Its homophilic interaction between endothe-
lium and leukocytes is described during diapedesis (Bogen
et al. 1992). CD105, endoglin, is expressed on angiogenic
endothelial cells and serves as a receptor for TGF (DuV
et al. 2003). Endothelial cell-selective adhesion molecule
(ESAM) co-localizes with cadherin/catenin proteins along
the lateral membrane of endothelial cells and is required for
the extravasation of neutrophils, but not lymphocytes, into
inXamed tissues (Hirata et al. 2001; Ishida et al. 2003;
Wegmann et al. 2006). CD146, also known as S-Endo 1
antigen, is a structural component of endothelial junctions
(Bardin et al. 1996b). It was initially found on melanoma
cells, thus formerly named MUC18 or melanoma cellular
adhesion molecule (Lehmann et al. 1989; Shih 1999).
CD146 has been reported to be functionally relevant for
endothelial cell adhesion and angiogenesis (Solovey et al.
2001; Yan et al. 2003). So far virtually all previous studies
focused on CD146 in humans. In the mouse only little is
known on the functional relevance of CD146, e.g. in
murine disease models.
In the present study we describe the monoclonal anti-
endothelial cell antibody ME-9F1 to recognize murine
CD146. By use of ME-9F1 we determined the tissue distri-
bution of CD146 in the mouse. Furthermore, the antibody
was shown to be useful for the identiWcation and isolation
of endothelial cells from various murine tissues.
Materials and methods
Antibodies
The hybridoma ME-9F1 was generated by standard fusion
technique after immunization of DA rats with the endothe-
lial cell line TME-3H3 as previously described (Duijvestijn
et al. 1987; Galfre and Milstein 1981; Harder et al. 1991).
Anti-human CD146 (MUCBA18.3) directed against the
cytoplasmic domain of human CD146 and being cross-
reactive to mouse was produced as described elsewhere
(Lehmann et al. 1989). Anti-VE-cadherin (11D4.1) was a
gift from Dietmar Vestweber, Max-Planck-Institut für
Molekulare Medizin, Münster, Germany. Anti-CD4
(GK1.5), anti-CD31 (3E2) and anti-Fc receptor II/III
(2.4G2/75) were obtained from the Deutsches Rheuma-
Forschungszentrum, Berlin, Germany. Meca32, anti-2-
integrin (DX5), anti-NK1.1 (PK136), anti-T cell receptor
(TCR) (H57-597) and all Xuorescent reagents were from
BD Biosciences, Heidelberg, Germany. Rat IgG and rabbit-
anti-rat antibody were from Dako Cytomation, Hamburg,
Germany.
Mice
Female C57BL/6 mice were obtained from the Bundesamt
für Risikobewertung, Berlin, Germany. CD146¡/¡ mice
were bred at the Institut für Immunologie, München, Ger-
many. CD146¡/¡ mice appear healthy, are fertile and breed
at normal ratios. Animal care was performed according to
the criteria published by the National Institutes of Health,
Bethesda, MD.
Endothelioma cell lines 
Murine skin derived endothelioma sEND and brain endo-
thelioma bEND5 (Rohnelt et al. 1997; Wagner and Risau
1994; Williams et al. 1989) were a gift from Britta Engel-
hardt, Bern, Switzerland. Murine mesenteric lymph node
derived endothelioma mlEND1 (Sorokin et al. 1994) were
provided by Rupert Hallmann, Münster, Germany. Cells
were cultured in Dulbecco´s minimal essential medium
(Cambrex Bio Science, Verviers, Belgium), supplemented
with 10% fetal calf serum (Invitrogen, Karlsruhe, Ger-
many) and harvested by detachment with Accutase (PAA
Laboratories, Pasching, Austria). In some experiments cells
were incubated with 50 g/ml ME-9F1 or isotype matched
control antibody while growing to conXuence. Phase con-
trast pictures were taken after 24 and 48 h from three diVer-
ent areas with a Leica DM IRE2 microscope (Leica
Microsystems, Wetzlar, Germany).
PuriWcation and identiWcation of the ME-9F1 antigen
Detached sEND were homogenized in 10 mM Tris/Chlo-
ride, pH 7.0, 250 mM sucrose (Merck, Darmstadt, Ger-
many). Membranes were isolated by sequential
centrifugation and solubilized by sonication and stirring on
ice for 1 h in detergent buVer containing 100 mM Tris/Chlo-
ride, pH 7.0; 100 mM NaCl and 1.2% 1-O-n-Octyl-beta-D-
glucopyranoside (Roche, Mannheim, Germany). For immu-
noadsorption the monoclonal antibody (mab) ME-9F1 or
isotype matched rat IgG were coupled to activated CH-
Sepharose 4B (Amersham Pharmacia Biotech, Freiburg,
Germany) according to the standard procedure given by the
manufacturer. After pre-adsorption with rat IgG-Sepharose,
the solubilized membrane fraction was incubated with ME-
9F1-Sepharose. Adsorbed proteins were eluated by heating
for 10 min at 90°C in SDS-PAGE sample buVer and sepa-
rated on a SDS-10% PAGE under reducing conditions. AfterHistochem Cell Biol (2008) 129:441–451 443
123
staining with Coomassie brilliant blue-R250 (Serva, Heidel-
berg, Germany) the protein band was excised and analyzed
by matrix-assisted laser-desorption ionization mass spec-
trometry (MALDI-MS) in a 4700 Proteomics Analyzer
(Applied Biosystems, Framingham, USA). The peptides of
Wve MS peaks were fragmented and further analyzed by
MS/MS. A Mascot search was performed in the Swiss-Prot
database (Sprot 20060124) with the following restrictions:
Variable modiWcations: N-Acetyl (Protein), Oxidation (M),
Propionamide (C), Pyro-glu (N-term Q); Cleavage by Tryp-
sin/P: cuts C-term side of KR; Mass values: monoisotopic;
Protein Mass: Unrestricted; Peptide Mass Tolerance:
§30 ppm; Fragment Mass Tolerance: §0.3 Da; Max Missed
Cleavages: 1. The protein was considered as identiWed if the
probability score was higher than 60 and the sequence cov-
erage higher than 30%.
For Western blot analysis 150 g protein from lung
lysate from wild type or CD146¡/¡ mice were separated on
a SDS-8% PAGE under reducing conditions, transferred to
nitrocellulose (Schleicher & Schüll, Dassel, Germany),
incubated with ME-9F1 or MUCBA18.3 and peroxidase
anti-mouse Ig (Lehmann et al. 1989). Bound antibodies
were visualized by the chemiluminiscense substrate West-
ern Lightning (Perkin Elmer, Rodgau-Jügesheim. Ger-
many).
Immunohistochemistry and immunoXuorescence 
microscopy
For immunostaining, 4 m-sections of formalin-Wxed, par-
aYn-embedded tissues were cut, deparaVinized and sub-
jected to a heat-induced epitope retrieval step. Sections
were immersed in sodium citrate buVer solution at pH 6.0
and heated in a high-pressure cooker for 2 min. Slides were
rinsed in cool running water, washed in Tris-buVered saline
(pH 7.4), treated with a biotin blocking agent (Dako, Glost-
rup, Denmark) and incubated with the primary antibody
ME-9F1 (5 g/ml) followed by biotinylated rabbit anti-rat
antibody and the streptavidine-conjugated alkaline phos-
phatase kit using Fast Red as chromogen (both from Dako).
Negative controls were performed by omitting the primary
antibody.
For double immunoXuorescence labeling, snap-frozen
material was used for ME-9F1/CD31 and paraYn blocks
for ME-9F1/lymphatic vessel endothelial hyaluronic acid
receptor (LYVE)-1 staining. Sections were incubated with
ME-9F1 followed by Alexa Fluor 555-conjugated anti-rat
antibody (1:100; Invitrogen, Carlsbad, CA, USA), washed
three times and incubated with Xuorescein isothiocyanate
(FITC)-conjugated anti-CD31 or rabbit polyclonal anti-
LYVE-1 antibody (1:1000; Biomol, Hamburg, Germany)
followed by Alexa Fluor 488-conjugated anti-rabbit anti-
body (1:100; Invitrogen). Nuclei were counterstained with
DAPI (1:1500; Roche, Mannheim, Germany) and mounted
in Fluoromount-G (Southern Biotech, Birmingham, Ala-
bama, USA). Negative controls were performed by omit-
ting the primary antibodies. Images were acquired using a
Xuorescence microscope (AxioImager Z1) equipped with a
CCD camera (AxioCam MRm) and processed with Axiovi-
sion software (Carl Zeiss MicroImaging GmbH, Carl Zeiss
AG, Oberkochen and Jena, Germany).
Flow cytometry
For  Xow cytometric analysis, single cell suspensions
blocked with 10 g/ml anti-Fc receptor II/III and rat IgG
were incubated with Xuorochrome-conjugated antibodies or
with biotinylated antibodies in conjunction with Xuoro-
chrome-conjugated streptavidine.
Ex vivo cell isolation and sorting of endothelial cells 
from various murine organs
Spleens were disrupted and passed through a Wne mesh to
obtain single cell suspensions. Hearts, lungs, kidneys and
livers were rinsed and digested with collagenase VI plus
DNase I (Sigma–Aldrich, Steinheim, Germany) as previ-
ously described (Klugewitz et al. 2002). Non-parenchymal
cells were further enriched by one-step density gradient
centrifugation with 26 % Nycodenz (Axis Shields, Oslo,
Norway). Endothelial cells were magnetically sorted using
ME-9F1 or Meca32 (Miltenyi Biotech, Bergisch Gladbach,
Germany). After over night culture non-adherent cells and
debris were removed by washing. Endothelial cells were
detached with Accutase and used for experiments. In some
experiments endothelial cells were incubated over night
with 1 g/ml acetylated low density lipoprotein (AcLDL,
Molecular Probes, Leiden, The Netherlands). The nuclei
were stained with Hoechst 33342 (Molecular Probes).
Transendothelial migration assay
BEND5 cells were cultured for 2 days on 5 m pore size
transwell plates (Corning, New York, NJ) (Rohnelt et al.
1997). Prior to the assay, cells were pre-incubated with
10 g/ml mab ME-9F1 or isotype matched control mab for
1 h or 20 h. In some experiments cells were further incu-
bated with 20 g/ml rabbit-anti-rat IgG to crosslink bound
anti-CD146 antibody. Pretreated cells were thoroughly
washed and the transwells placed into new cavities. Forma-
tion of endothelial cell layers was analyzed by quantifying
the number of endothelial cells by phase contrast micros-
copy. Subsequently, transendothelial migration assays were
performed as previously described (Siegmund et al. 2005).
BrieXy, 5 £ 105 T cells were added to the upper and 10 nM
CXC-chemokine ligand 12 (CXCL12) (R&D Systems,444 Histochem Cell Biol (2008) 129:441–451
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Minneapolis, MN, USA) was added to the lower chamber.
Transmigrated T cells were harvested after 90 min incuba-
tion. The rate of transmigration was quantiWed by Xow
cytometry after staining cells for CD4 and adding Fluoresb-
rite™ 20 m microspheres (Polysciences, Warrington, PA,
USA).
Results
The mab ME-9F1 recognizes murine CD146.
The ME-9F1 antigen was enriched by immunoadsorption
from solubilized membranes of endothelial cells and sepa-
rated by SDS-PAGE. The protein band not seen in the neg-
ative control without soluble membrane fraction and after
pre-adsorption with rat IgG had a molecular ratio above
97 kDa (Fig. 1a) and was subjected to analysis by MALDI-
MS (Fig. 1b). A Mascot search from fragmented peptides
of Wve MS peaks analyzed by MS/MS (inset) resulted in the
identiWcation of CD146 (Q8R2Y2) with a score of 386, a
sequence coverage of 35% and 24 matched peptides.
The speciWcity of the mab ME-9F1 for CD146 was con-
Wrmed by Western blot analysis of lung protein from wild
type and CD146¡/¡ mice (Fig 1c). Both antibodies
MUCBA18.3 and ME-9F1 detected a distinct band corre-
sponding to a molecular ratio of about 113 kDa in wild
type, but not in CD146¡/¡ mice. Thus, we were able to
identify CD146 as the target antigen of the mab ME-9F1
raised against endothelial cells.
CD146 is strongly expressed by murine vascular 
endothelial cells and at lower levels on a subset 
of NK1.1+ cells
The tissue distribution of murine CD146 was Wrst analyzed
by immunohistochemistry using tissue sections of healthy
murine organs. Staining was possible on cryopreserved
material (data not shown) and on paraYn-embedded sec-
tions (Fig. 2). In non-lymphoid tissues, CD146 expression
was detected in the endothelial cells of pulmonary arteries,
veins and the capillary network of the alveolar walls. It is
similarly expressed in the arteries, veins and the glomerular
capillaries of the kidney. In the liver, the mab ME-9F1
Fig. 1 Preparation and identiW-
cation of the ME-9F1 antigen. a 
SDS-PAGE analysis after im-
munoadsorption of solubilized 
membrane fractions of murine 
endothelioma cells with ME-
9F1-Sepharose. Eluates of con-
trol-Sepharose and of control-
Sepharose after incubation with 
membrane fraction (pre-adsorp-
tion) served as controls. b Pep-
tide mass Wngerprint of the SDS-
PAGE separated ME-9F1 anti-
gen by MALDI-MS. Inset: MS/
MS spectrum of the peak with 
the mass of 1016.45. c Western 
Blot analysis of lung lysate from 
wild type or CD146¡/¡ mice af-
ter staining with MUCBA18.3 or 
ME-9F1 and peroxidase anti-
mouse IgG. The mouse IgG 
heavy chain served as equal 
loading control
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stains larger blood vessels and particularly the liver sinusoi-
dal endothelial cells (LSEC) (Fig. 2a, upper panel). In lym-
phoid tissues, ME-9F1 marks the endothelium of arterioles
and capillaries in the spleen and the high endothelial ven-
ules in lymph nodes (Fig. 2a, lower panel) and within
Peyer´s patches (data not shown). The section of the small
intestine shows CD146 expression in the capillary tree of
the lamina propria and in the ganglion cells of the myen-
teric plexus. Homogeneous staining of vascular endothe-
lium was also found in other organs, such as brain, heart
and skeletal muscle. Double immunoXuorescence labeling
showed co-expression of CD31 and CD146 by endothelial
cells of an arteriole and an adjacent glomerulum in the kid-
ney (Fig. 2b, upper panel). AVerent lymph vessels in the
subcapsular sinus of a lymph node were detected by
LYVE-1 expression. In contrast, ME-9F1 did not bind to
lymphatic endothelium but instead stained high endothelial
venules (Fig. 2b, lower panel). In summary, ME-9F1 binds
to vascular, but not to lymphatic endothelium.
In  Xow cytometry the endothelioma cell lines sEND,
bEND5 and to a lesser degree mlEND1 were stained
brightly and homogenously by ME-9F1 (Fig. 3a). To ana-
lyze CD146 expression on primary endothelial cell popula-
tions, cell suspensions from heart, lung, kidney and liver
were stained with ME-9F1. Ex vivo-isolated non-lymphoid
cell populations are usually heterogeneous, resulting in
varying autoXuorescence. High levels of CD146 expression
tightly correlated to the expression of the other endothelial
markers CD31, VE-cadherin and the Meca32 antigen in
heart, lung and liver (Fig. 3b). In contrast, kidney endothe-
lial cells deWned by the latter markers displayed a lower
expression of CD146.
Apart from CD146high endothelial cells, we detected a
signiWcant population of non-endothelial cells expressing
Fig. 2 Tissue distribution of 
CD146 in murine organs. a Par-
aYn tissue sections (4 m) were 
subsequently stained with the 
mab ME-9F1, biotinylated rab-
bit anti-rat antibody and strepta-
vidine-alkaline phosphatase and 
developed with Fast Red, result-
ing in a red labeling of the endo-
thelial cells of the blood vessels. 
Original magniWcation £200. b 
Snap-frozen kidney tissue was 
stained for CD31 (green) and 
CD146 (red) (upper panel). 
Original magniWcation £200. 
ParaYn tissue sections of lymph 
nodes were stained using a poly-
clonal antibody against LYVE-1 
(green) and ME-9F1 against 
CD146 (red) (lower panel). 
Original magniWcation £100. 
Nuclei were counterstained with 
DAPI (blue). Pictures represen-
tative for Wve mice studied inde-
pendently446 Histochem Cell Biol (2008) 129:441–451
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low levels of CD146 in most tissues. We further character-
ized these cells from spleen (data not shown) and liver
(Fig. 3c). They had low forward and side scatter character-
istics in Xow cytometry typical for lymphoid cells and were
negative for endothelial markers, such as for the Meca32
antigen. The majority of these CD146low lymphoid cells
expressed NK1.1 and 2-integrin but was virtually negative
for TCR, identifying them as natural killer (NK) cells.
Murine primary endothelial cells from various organs can 
be immunomagnetically sorted ex vivo due to their CD146 
expression
To test if CD146 is also suitable for the enrichment of
endothelial cells from diVerent parenchymal organs, ME-
9F1 was used for positive magnetic cell sorting. We could
isolate endothelial cells from lung, kidney and liver
Fig. 3 Detection of endothelial 
and non-endothelial cells using 
ME-9F1 in Xow cytometry. a 
Endothelioma sEND, bEND5 
and mlEND1 were stained with 
ME-9F1 (bold line) or the 
respective isotype for negative 
control (thin line). b Ex vivo-
isolated cell suspensions from 
heart, lung, kidney and liver 
were labeled with ME-9F1, 
counterstained with anti-CD31, 
anti-VE-cadherin and Meca32 
and analyzed by Xow cytometry. 
c Ex vivo-isolated non-paren-
chymal liver cells were stained 
with ME-9F1 in conjunction 
with mab against the Meca32 
antigen, NK1.1, 2-integrin or 
TCR and analyzed by Xow 
cytometry. Histograms and dot 
plots showing lymphoid cells, 
identiWed by low forward and 
side scatter characteristics are 
representative for at least four 
independent experiments
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(Fig. 4). Percentages of endothelial cells from lung and kid-
ney were increased from initially 1–6% to over 60%, yield-
ing approximately 3 £ 105 and 1.5 £ 105 endothelial cells
per organ, respectively. Magnetic sorting of LSEC resulted
in a purity of 80-90% and a yield of (2.1 § 1.5) £ 106
endothelial cells per liver. When organized to monolayers,
the cells showed the typical endothelial morphology
(Fig. 5a) and eYciently took up AcLDL as shown by Xuo-
rescence microscopy (Fig. 5b) and Xow cytometry
(Fig. 5c). After over night culture the purity of vital LSEC
was further increased up to 95–98%. Upon 6 days of in
vitro culture LSEC maintained the typical expression pat-
tern of endothelial cell markers including CD146 (Fig. 5d).
ME-9F1 does not aVect endothelial cell growth or trans-
endothelial T cell migration in vitro. For human cells,
blocking of CD146 was reported to exert eVects on endo-
thelial integrity. We therefore tested whether binding of
ME-9F1 might inXuence the formation and function of an
endothelial monolayer. The endothelioma cells mlEND1,
bEND5 (data not shown) and sEND (Fig. 6a) incubated
with ME-9F1 during culture grew similarly. Cell morphol-
ogy in the monolayers in the absence or presence of ME-
9F1 was indistinguishable. To address if ME-9F1 aVects
transendothelial migration of T cells, bEND5 cells were
incubated with ME-9F1 with or without Fc-mediated anti-
body crosslinking (Fig. 6b). Neither the spontaneous nor
the chemokine-induced transendothelial migration of CD4+
T cells as shown for CXCL12 was altered after pre-incubat-
ing the endothelial cells with ME-9F1. We conclude that
the mab ME-9F1 is not blocking structures of CD146 that
are functionally involved in these processes.
Discussion
CD146 is a transmembrane glycoprotein and belongs to the
IgG superfamily of cell adhesion molecules (Sers et al.
1993). In humans, CD146 is described to be expressed on
all types of endothelial cells independent of vessel size or
site. It is preferentially localized at intercellular endothelial
junctions (Bardin et al. 2001,1996a). Human CD146
expression is not completely restricted to endothelial cells.
Low levels are also found on melanoma cells (Lehmann
et al. 1989; Shih 1999), smooth muscle cells, follicular den-
dritic cells (Bardin et al. 1996b) and a small subpopulations
of activated T cells (Pickl et al. 1997). We identiWed murine
CD146 as the antigen recognized by the mab ME-9F1 by
immunoprecipitation and mass spectrometry and conWrmed
the results by use of CD146¡/¡ mice. Using ME-9F1, we
were able to study the distribution of CD146 in the murine
system.
Corresponding to humans, we detected high levels of
CD146 expression on endothelial cells of murine vessels
throughout the body. We also observed low expression lev-
els of CD146 on non-endothelial cells in several organs of
mice. However, in contrast to humans, we did not detect
signiWcant CD146 expression in smooth muscle cells of any
organ investigated. T cells and follicular dendritic cells
were also CD146¡, as all non-endothelial CD146low cells
from spleen and liver were TCR¡ and FDC-M2¡ (G.
Wittenburg, personal communication). Since murine
CD146+ non-endothelial cells from spleen and liver co-
expressed NK1.1 and 2-integrin, they appear to represent
a distinct subpopulation of NK cells (Yokoyama and Sea-
man 1993) that are especially abundant in the liver (Crispe
2003; Doherty et al. 1999). Expression on human endothe-
lial and activated T cells has led to the speculation that
CD146 plays a physiological role for leukocyte traYcking
(Pickl et al. 1997). It remains to be investigated, if murine
CD146 is involved in the migration of NK cells.
Some markers have been proven to be suitable for the
detection of endothelial cells, such as CD31, Meca32 anti-
gen, von Willebrand Factor, ESAM or CD105 (endoglin)
ESAM (Ge and Butcher 1994; Nasdala et al. 2002). Several
issues restrict their use for the ex vivo isolation of endothe-
Fig. 4 Enrichment of endothelial cells from various organs by mag-
netic sorting with ME-9F1. Ex vivo-isolated cells from lung, kidney
and liver were subjected to magnetic sorting using ME-9F1. Endothe-
lial cells within the positive fractions were subsequently co-stained
with Meca32 and detected by Xow cytometry. Dot plots show represen-
tative data from 3–8 independent experiments
M
e
c
a
3
2
 
a
n
t
i
g
e
n
61
67
85
unstained control
0
0
0
CD146
kidney
lung
liver448 Histochem Cell Biol (2008) 129:441–451
123
lial cells. These molecules are either not as speciWc (Bogen
et al. 1992; Piali et al. 1993), are not highly expressed on
all endothelial cells (Hallmann et al. 1995) or need to be
detected intracellularly (Hoyer et al. 1973; Pusztaszeri et al.
2006).
The mab ME-9F1 described in this study detects all
kinds of endothelial cells of blood vessels along the entire
vascular tree in all murine organs investigated (e.g. lung,
heart, kidney, liver, spleen, lymph node, intestine, brain,
skin) without labeling lymphatic endothelium. It is useful
not only for immunohistochemistry of cryopreserved and
paraYn-embedded samples but also for Western blot and
Xow cytometry, the latter additionally attributing the epi-
tope for ME-9F1 to the extracellular domain of CD146. Of
the methods established for the ex vivo isolation of endo-
thelial cells, out-growing from tissue sections is only prac-
ticable for larger murine vessels (Nicosia et al. 1994),
density gradient centrifugation has to be followed by cul-
ture for a week to reach conXuence (Veszelka et al. 2007)
and isolation of liver endothelium by centrifugal elutriation
requires signiWcant technical equipment (Knook and Sley-
ster 1976). In contrast, magnetic sorting with the mab ME-
9F1 provides large endothelial cell numbers immediately
after ex vivo isolation which makes it useful for, e.g., RNA
Fig. 5 Analysis of ex vivo-iso-
lated LSEC after culture. LSEC 
were enriched by magnetic cell 
sorting using ME-9F1. a After in 
vitro culture over night morphol-
ogy was assessed by phase con-
trast microscopy (bar = 50 m). 
The uptake of AcLDL by LSEC 
was analyzed by b Xuorescence 
microscopy (AcLDL, green; nu-
cleus staining with Hoechst 
33342, blue) or c Xow cytometry 
after counterstaining with ME-
9F1. d The expression of CD31, 
VE-cadherin and Meca32 anti-
gen (bold line) was analyzed by 
Xow cytometry at day 0 and 6 af-
ter in vitro culture. The respec-
tive isotypes were stained for 
negative control (thin line). Data 
shown are representative from 
least four independent experi-
ments
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micro arrays. Directly labeled magnetic beads making the
procedure easy and eYcient are described for preparation
of LSEC (Hegenbart et al. 2006). But sorting by CD146 is
not limited to LSEC, as we and others could also enrich
endothelial cells from other organs and even from tumors
(Berger et al. 2005). Over night adhesion of enriched LSEC
followed by thorough washing the cell layer results in
higher purity with regard to the endothelial cells. The non-
adherent fraction could be used for further investigations
e.g. of CD146low NK cells.
The endothelial CD146 expression is regulated during
monolayer formation and inXuences the paracellular per-
meability (Bardin et al. 2001; Solovey et al. 2001). Further-
more, CD146 plays a role in signal transduction. The
outside-in signalling results in recruitment of the Src-fam-
ily kinase FYN and the phosphorylation of FAK or paxillin,
two proteins found in focal adhesion plaques. These results
were obtained with an activating anti-human CD146 mab
(S-Endo 1) (Anfosso et al. 1998, 2001). Here we demon-
strated that ME-9F1 did not alter functional properties of
murine endothelial cells. Neither the endothelial growth nor
the transendothelial migration of T cells were increased or
impaired by this mab. Also in Ca2+ inXux assays (data not
shown) we did not observe endothelial cell activation after
preincubation with ME-9F1. This makes the antibody espe-
cially suitable for the ex vivo isolation of endothelial cells
for functional studies.
In conclusion, our study describes a new tool for the
detection and isolation of CD146+ cells and shows that
CD146 is also in the murine system a component constitu-
tive for all types of blood vessel endothelial cells. In addi-
tion, low levels were identiWable on NK cells, but not on
NKT cells, T cells, follicular dendritic cells or smooth mus-
cle cells. Recently, CD146 has also been described as a use-
ful marker for circulating endothelial progenitor cells
(Delorme et al. 2005). Although not tested so far in the
mouse, ME-9F1 could allow transferring such studies into
the murine system.
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